| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/20/2001 | US6203984 Using single-stranded dna of promoter, restriction enzyme site, oligonucleotide dt and coding sequences; ligating forming catenates or circular dna; adding complementary dna; cleaving at site; form template for messenger rna production |
| 03/20/2001 | US6203979 Polynucleotide which codes for protein of defined amino acid sequences; diagnosis, prevention, and therapy of cell proliferative and immune disorders; anticarcinogenic agents; antiproliferative/antiarthritic agents; crohn's disease |
| 03/20/2001 | US6203976 Drug screening using eukaryotic cells with dna construct of regulatory sequence and promoter linked to reporter gene, contacting with chemical, quantitatively determining signal produced, comparing to controls, then mixing with carrier |
| 03/20/2001 | US6203975 Adenovirus and method of use thereof |
| 03/20/2001 | US6203974 Chemiluminescent immunoassay for detection of antibodies to various viruses |
| 03/20/2001 | US6203801 Coccidiosis polypeptide and vaccines |
| 03/20/2001 | US6203800 Screening for antibacterial agents; genetic engineering |
| 03/20/2001 | US6203799 Cholera vaccines; deleted mutant strain |
| 03/20/2001 | US6203798 Lyme disease diagnosis and vaccines; genetic engineering |
| 03/20/2001 | CA2318519A1 Genes and polypeptides associated with ultraviolet radiation-mediated skin damage and uses thereof |
| 03/20/2001 | CA2211385C N-1-carboxyalkyl derivatives of lsd |
| 03/20/2001 | CA2098303C Synthetic bioadhesive polypeptide |
| 03/20/2001 | CA2033657C Glucose isomerases having altered substrate specificity |
| 03/20/2001 | CA2022959C Cat-mouse heterohybridoma and gene fragment coding for constant region of feline immunoglobulin |
| 03/15/2001 | WO2001018549A1 Method for identifying modulators of daf-16 |
| 03/15/2001 | WO2001018547A1 Essential genes and assays relating thereto |
| 03/15/2001 | WO2001018546A2 Screening for inhibitors of 'paired helical filaments' |
| 03/15/2001 | WO2001018253A1 Gene manipulation method using homologous recombination |
| 03/15/2001 | WO2001018252A2 Methods for disease detection |
| 03/15/2001 | WO2001018251A1 Methods of determining the presence of double stranded nucleic acids in a sample |
| 03/15/2001 | WO2001018245A2 Detection of alterations in a gene by long range pcr using human mobile elements |
| 03/15/2001 | WO2001018244A2 Selection system |
| 03/15/2001 | WO2001018240A2 Diagnostic and therapeutic methods in autoimmune disease |
| 03/15/2001 | WO2001018236A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | WO2001018234A1 Method to identify gene function using small molecule probes |
| 03/15/2001 | WO2001018233A2 Screening for inhibitors of lumazine synthase |
| 03/15/2001 | WO2001018232A2 Drug target isogenes: polymorphisms in the uncoupling protein 3 (mitochondrial, proton carrier) gene |
| 03/15/2001 | WO2001018225A1 Targeting constructs and transgenic animals produced therewith |
| 03/15/2001 | WO2001018224A1 Adenoviral vectors modified for increased and persistent expression of the cystic fibrosis transmembrane conductance regulator gene in human airway epithelia |
| 03/15/2001 | WO2001018223A1 Paramyxoviruses having modified transcription initiation sequence |
| 03/15/2001 | WO2001018222A1 Methods and compositions for the chromosomal integration of heterologous sequences |
| 03/15/2001 | WO2001018221A1 Nucleic and amino acid sequences relating to resistance to blackleg in plants |
| 03/15/2001 | WO2001018220A1 Modified ubiquitin regulatory system |
| 03/15/2001 | WO2001018219A1 Regulatory sequences functioning in filamentous fungi |
| 03/15/2001 | WO2001018218A1 Expression of proteins in genetically modified fungi |
| 03/15/2001 | WO2001018217A2 Thermus promoters for gene expression |
| 03/15/2001 | WO2001018216A2 26176, a novel calpain protease and uses thereof |
| 03/15/2001 | WO2001018215A1 Method for producing active serine proteases and inactive variants |
| 03/15/2001 | WO2001018214A1 Nucleic acids encoding ribonucleases and methods of making them |
| 03/15/2001 | WO2001018213A1 Chimeric thermostable dna polymerases |
| 03/15/2001 | WO2001018212A2 Mycobacterium paratuberculosis-specific antigens and their diagnostic uses |
| 03/15/2001 | WO2001018211A1 Sugarcane plant promoters to express heterologous nucleic acids |
| 03/15/2001 | WO2001018210A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | WO2001018209A1 Fibroblast growth factor polypeptide and nucleic acids encoding same |
| 03/15/2001 | WO2001018208A2 Interferon induced polynucleotides and proteins encoded thereby |
| 03/15/2001 | WO2001018207A1 Human 7tm proteins receptors and polynucleotides encoding the same |
| 03/15/2001 | WO2001018206A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 03/15/2001 | WO2001018205A1 Secreted polypeptide zalpha30 |
| 03/15/2001 | WO2001018204A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | WO2001018203A1 Opg fusion protein compositions and methods |
| 03/15/2001 | WO2001018202A2 Flint analog compounds and formulations thereof |
| 03/15/2001 | WO2001018201A1 Pesticidal activity of plant essential oils and their constituents |
| 03/15/2001 | WO2001018200A1 Tsg-like gene |
| 03/15/2001 | WO2001018199A1 Chimaeric plant viruses with mucin peptides |
| 03/15/2001 | WO2001018198A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/15/2001 | WO2001018197A1 Genetic screening methods |
| 03/15/2001 | WO2001018196A1 Method of detecting trichothecene mycotoxins and reagent thereof |
| 03/15/2001 | WO2001018195A2 Luciferase expression cassettes and methods of use |
| 03/15/2001 | WO2001018194A2 Maize casein kinase 1 orthologue and uses thereof |
| 03/15/2001 | WO2001018193A1 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 03/15/2001 | WO2001018192A2 Synthetic vectors, transgenic plants containing them, and methods for obtaining them |
| 03/15/2001 | WO2001018191A2 Polynucleotides and polypeptides of the phosphoenolpyruvate carboxylase kinase (pepc kinase) family and their variants |
| 03/15/2001 | WO2001018190A2 Dihydroorotase extracted from plants |
| 03/15/2001 | WO2001018189A2 Method for expressing exogenous sequences in mammalian cells |
| 03/15/2001 | WO2001018186A1 A NOVEL TYPE II RESTRICTION ENDONUCLEASE, Hpy188I, OBTAINABLE FROM HELICOBACTER PYLORI J188 AND A PROCESS FOR PRODUCING THE SAME |
| 03/15/2001 | WO2001018185A1 High level cytokine production with enhanced cell viability |
| 03/15/2001 | WO2001018184A1 Variant nucleoside-5'-phosphate producing enzyme |
| 03/15/2001 | WO2001018183A1 Methods and compositions for production of floral scent compounds |
| 03/15/2001 | WO2001018182A1 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 2 promoter and terminator |
| 03/15/2001 | WO2001018178A1 Nucleic acids and polypeptides of invertebrate bioamine transporter and methods of use |
| 03/15/2001 | WO2001018177A1 Method and system for non-random selection of plant and tissue products |
| 03/15/2001 | WO2001018176A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018175A1 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018170A2 Conditional inhibition of vegetative propagation |
| 03/15/2001 | WO2001018169A2 Agents and compositions and methods for diagnostic and/or treating or preventing plaque forming diseases |
| 03/15/2001 | WO2001018168A1 Device for introducing pores into biological materials |
| 03/15/2001 | WO2001018124A1 Red-emitting [8,9]benzophenoxazine nucleic acid dyes and methods for their use |
| 03/15/2001 | WO2001018061A2 Maize polynucleotides and related polypeptides useful for enhancing disease resistance in crop plants |
| 03/15/2001 | WO2001018058A2 Enhanced phage display library of human vh fragments and methods for producing same |
| 03/15/2001 | WO2001018056A2 Method of gene therapy for improving the efficiency of cancer therapy |
| 03/15/2001 | WO2001018054A1 Monkey gpr14 |
| 03/15/2001 | WO2001018053A1 Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla |
| 03/15/2001 | WO2001018052A1 Monomeric analogues of human insulin |
| 03/15/2001 | WO2001018051A2 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 03/15/2001 | WO2001018050A2 T2r taste receptor family |
| 03/15/2001 | WO2001018049A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018048A2 Smooth muscle cell promoter and uses thereof |
| 03/15/2001 | WO2001018047A1 Dendritic cell membrane protein fire |
| 03/15/2001 | WO2001018045A1 Crystal structure of a deacetylase and inhibitors thereof |
| 03/15/2001 | WO2001018043A2 Neurogenic compositions and methods |
| 03/15/2001 | WO2001018042A2 Apoptosis proteins |
| 03/15/2001 | WO2001018038A2 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 03/15/2001 | WO2001018035A2 Muc-1 derived peptides |
| 03/15/2001 | WO2001018033A1 Gamma-carboxyglutamate containing conopeptides |
| 03/15/2001 | WO2001018024A1 Antisense modulation of x-linked inhibitor of apoptosis expression |
| 03/15/2001 | WO2001018023A1 Antisense modulation of pi3 kinase p110 beta expression |
| 03/15/2001 | WO2001018022A1 52 human secreted proteins |
| 03/15/2001 | WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018020A1 A eukaryotic mechanosensory transduction channel |